Teva Pharma Industries (NYSE: TEVA) — Company Overview, News & Financial Data
Teva Pharma Industries develops generic and specialty medicines globally, enhancing access to affordable healthcare across various therapeutic areas.
Teva Pharma Industries
Teva Pharma Industries is a global biopharmaceutical company engaged in the development, manufacturing, and commercialization of generic medicines, biosimilars, over-the-counter health products, and specialty innovative pharmaceuticals. The company's product portfolio focuses on therapeutic areas including neuroscience, immunology, oncology, and respiratory care. Teva operates an integrated commercial and supply chain infrastructure spanning North America, Europe, and international growth markets, delivering medicines to healthcare systems and patients worldwide. Its business model combines a global scale generics and biosimilars operation with ongoing research and development into novel biopharmaceutical treatments and targeted therapeutic solutions.
Snapshot
Operations
Products and/or services of Teva Pharma Industries
- Generic Medicines: Manufacturing and global distribution of prescription generic pharmaceuticals across oral solid dosage forms, injectables, respiratory inhalers, and complex formulations, providing cost-effective treatments across primary therapeutic areas and regional healthcare markets.
- Innovative Neuroscience Medicines: Development and commercialization of specialized branded prescription pharmaceuticals for central nervous system disorders, focusing on movement disorders, severe psychiatric conditions, tardive dyskinesia, and targeted preventive treatments for chronic migraine.
- Biosimilar Products: Development, strategic partnering, and commercial distribution of follow-on biological therapies across oncology and immunology, offering high-quality biological treatment options that expand patient access to complex biopharmaceutical remedies worldwide.
- Immunology and Respiratory Therapies: Commercialization and advanced clinical pipeline development of targeted biopharmaceutical products for autoimmune diseases, inflammatory bowel conditions, asthma, and chronic obstructive pulmonary disease across major international markets.
- Over-the-Counter Consumer Healthcare: Formulation, production, and distribution of non-prescription consumer healthcare products, self-care remedies, and dietary supplements sold through retail pharmacies and commercial distribution networks across Europe and international markets.
- Active Pharmaceutical Ingredients: Development, chemical synthesis, and commercial supply of bulk active pharmaceutical ingredients and active intermediates to internal drug production operations as well as external third-party pharmaceutical manufacturers worldwide.
Teva Pharma Industries executive team
- Mr. Richard D. FrancisPresident, CEO & Director
- Mr. Eliyahu Sharon KalifExecutive VP & CFO
- Mr. Richard Gordon DaniellExecutive Vice President of European Commercial
- Dr. Eric A. Hughes M.D., Ph.D.Executive VP of Global R&D and Chief Medical Officer
- Ms. Christine FoxExecutive VP of U.S. Commercial Business
- Mr. Matthew ShieldsExecutive Vice President of Global Operations
- Mr. Amir WeissSenior VP & Chief Accounting Officer
- Mr. Christopher J. Stevo CFASenior Vice President of Investor Relations & Competitive Intelligence
- Kathleen VeitSenior Vice President, Global Compliance & Ethics Officer
- Mr. David R. Mcavoy J.D.Executive VP & Chief Legal Officer